• No results found

Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management

N/A
N/A
Protected

Academic year: 2021

Share "Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management"

Copied!
6
0
0

Loading.... (view fulltext now)

Full text

(1)

Brochure

More information from http://www.researchandmarkets.com/reports/2226324/

Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC

and RFID Enhance Drug Supply Management

Description: Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management

Summary

GBI Research, leading business intelligence provider has released its latest research report, entitled “Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply

Management”. The report focuses on the current scenario of clinical supply chain management. Key segments of the clinical supply chain which are covered in the report include labeling, packaging, warehousing, logistics, distribution and destruction of investigational products.

There has been an increase in the number of developmental drugs, and an expansion in clinical trial sites and the complexity of clinical trials. There has also been an increase in the total number of procedures undertaken per clinical trial.

Clinical Supply Chain Management (CSCM) is vital in conducting clinical trials. Geographic expansion, the complexity of drugs used in clinical trials and the increased attention of pharmaceutical companies on efficient R&D are the three main reasons for having proper CSCM in place. Accurate and timely delivery of clinical trial material to the clinical trial site is critical for the success of a clinical trial. The chance of meeting the research milestones increases by considering clinical supply processes from the planning stage of the clinical trials.

Although there are many advantages of tracking clinical trial products, it is very difficult to have an efficient process in place to track inventory. Use of new technologies is done to make tracking more efficient and effective. Pharmaceutical companies are looking for better avenues, such as Contract Research

Organizations (CROs) who have dedicated departments that leverage information technology to rejuvenate their business model, particularly R&D, and make it more agile, lean and global. Information technology provides significant potential to make this happen through various services, which include globally integrated data management, paperless clinical trials and many others.

Scope

- Segmentation of the clinical supply industry by its major components such as logistics and inventory management.

- Key challenges and unmet needs of the clinical supply chain management industry.

- Analysis of technologies such as IVRS/IWRS, RFID and others which are used for efficient clinical supply chain operations.

- Regulatory landscape of countries such as China, India, Russia and South Africa. - Key parameters which are considered for choosing the clinical supply vendor. - Profiles of key companies which deal in clinical supply chain management.

- Analysis of factors which are considered for outsourcing the clinical supply chain to other companies. Reasons to buy

- Decide on the existing market scenario in clinical supply chain management.

(2)

- Gain knowledge of key challenges and unmet needs for the clinical supply chain management industry. - Develop strategies for quality control of clinical supply materials.

- Develop risk mitigation strategies to enhance risk management.

Contents: 1 Table of Contents 1.1 List of Tables 1.2 List of Figures

2 Clinical Supply Chain Management - Introduction 3 Clinical Supply Chain Management - Overview 3.1 Overview of Clinical Supply Chains

3.1.1 Evolution of Clinical Supply Chains

4 Clinical Supply Chain Management - Industry Analysis 4.1 Capital Requirement

4.2 Skilled Workforce

4.3 Competition Among Existing Players

5 Clinical Supply Chain Management - Drivers and Restraints 5.1 Drivers

5.1.1 Increasing Concern for Pharmaceutical Companies to Improve R&D Outcomes 5.1.2 Geographic Expansion for Conducting Clinical Trials

5.2 Restraints

5.2.1 Complex Regulatory System

5.2.2 High Cost Involved for Entering the Market and Maintaining Processes

5.2.3 Proper Visibility of Products in the Supply Chain (Inventory Visibility and Traceability) 6 Clinical Supply Chain Management - Components of the Clinical Supply Chain

6.1 Labeling 6.2 Packaging

6.2.1 Blister Packaging 6.2.2 Plastic Bottles

6.2.3 Labels and Accessories 6.2.4 Pouches and Strip Packs 6.2.5 Caps and Closures 6.2.6 Secondary Containers 6.2.7 Others

6.3 Logistics

6.3.1 Focus Areas for Logistics 6.4 Distribution Models 6.4.1 Outsource 6.4.2 Build 6.4.3 Acquisition 6.4.4 Direct Shipping 6.4.5 Co-Development 6.5 Inventory Management

6.6 Destruction and Disposal of Waste 6.6.1 Recording of Destruction 6.6.2 Methods of Destruction

7 Clinical Supply Chain Management - CROs Operate in Clinical Trial Supplies 7.1 Key Reasons for Outsourcing of Clinical Trials and Research Processes

7.1.1 Different Strategies Adopted by Pharmaceutical Companies to Increase Efficiency

7.1.2 Increase in the R&D Costs Against Revenue Growth is a Reason for Outsourcing Clinical Trials to CROs 7.1.3 Increasing Drug Failure Rates a Concern for Pharmaceutical Companies

7.1.4 Outsourcing Clinical Trials to CROs in Order to Decrease the Time Required for Launching the Product in the Market

7.1.5 Outsourcing to Site Management Organizations (SMO)

(3)

Outsourcing

7.1.7 CROs Can Effectively Manage the Trends in Regulations Governing Clinical Trials 7.2 Factors Leading to CSMO Growth

8 Clinical Supply Chain Management - Key Challenges for Effective and Efficient Supply Chain Management 8.1 Key Factors for Efficient Supply Chain Management in Clinical Trials

8.1.1 Planning Issues 8.1.2 Manufacturing Issues 8.1.3 Distribution Issues 8.1.4 Visibility Issues

8.1.5 Technical Integration with the Vendors

9 Clinical Supply Chain Management - Technological Landscape 9.1 Information Technology in R&D

9.1.1 Data Management

9.1.2 Clinical Data Management System 9.1.3 Clinical Data Management Outsourcing

9.1.4 Deals in Clinical Trial Data Management Outsourcing 9.2 IVRS/IWRS

9.2.1 IVRS Provides Real-Time Clinical Trials Data Tracking for the Following 9.2.2 Case Study

9.3 Clinical Data Management Systems (CDMS)/Clinical Trial Management Systems (CTMS) 9.4 Electronic Data Capture (EDC)

9.5 Clinical Trial Management System (CTMS) 9.6 Radio Frequency Identification (RFID)

10 Clinical Supply Chain Management - Regulatory Landscape 10.1 The US

10.1.1 Important Regulations by the FDA in Proposal

10.1.2 FDA Motivating CROs to Use Adaptive Design in Drug Development 10.2 Europe

10.2.1 The New Pharmacovigilance Legislation 10.2.2 Reasons for Passing the New Legislation 10.3 Emerging Markets

10.4 India

10.4.1 Potential Advantages of the Indian CRO Market 10.5 China

10.5.1 Potential Advantages of the Chinese CRO Market

11 Clinical Supply Chain Management - Profiles of Key Players and Key Deals 11.1 Profiles of Key Companies in Clinical Supply Chain Management 11.1.1 Medidata

11.1.2 Catalent 11.1.3 Myoderm

11.1.4 Cold Chain Technologies 11.1.5 Numoda Corporation 11.1.6 Fisher Clinical Services 11.1.7 Marken

11.1.8 Phase Forward

11.1.9 Bilcare Global Clinical Supplies 11.1.10 Almac Clinical Services 11.1.11 BioClinica

11.1.12 Aptuit 11.1.13 Chiltern

11.2 Key Deals among Clinical Supply Management Companies 11.2.1 Medidata Solutions Acquired Clinical Force in July 2011

11.2.2 Catalent Acquires Clinical Trial Supplies Division of Aptuit LLC in February 2012 11.2.3 Ion Beam Applications (IBA) and Bayer Schering Pharma Sign a Deal in 2010 12 Clinical Supply Chain Management - Appendix

12.1 Market Definitions 12.2 Abbreviations 12.3 Bibliography

(4)

12.4 Research Methodology 12.4.1 Coverage

12.4.2 Secondary Research 12.4.3 Primary Research 12.4.4 Expert Panel Validation 12.5 Contact Us

12.6 Disclaimer 1.1 List of Tables

Table 1: Clinical Supply Chain Management, Clinical Trials in Different Geographies, %, 2012 Table 2: Clinical Supply Chain Management, R&D Expenditure Versus Turnover for the Top Ten Pharmaceutical Companies, 2011

1.2 List of Figures

Figure 1: Clinical Supply Chain Management, Investigational Medicinal Products (IMP) Path, 2012 Figure 2: Clinical Supply Chain Management, Clinical Trials in Different Geographies, %, 2012

Figure 3: Clinical Supply Chain Management, Illustrative Supply Chain for Clinical Trial Materials, 2012 Figure 4: Clinical Supply Chain Management, Capital Requirement, Stages, 2012

Figure 5: Clinical Supply Chain Management, Advantages of Geographic Expansion of Clinical Trials, 2012 Figure 6: Clinical Supply Chain Management, Types of Clinical Trial Material Packaging, 2012

Figure 7: Clinical Supply Chain Management, Key Stages in Distribution of Clinical Trial Material, 2012 Figure 8: Clinical Supply Chain Management, Key Focus Areas for Logistics, 2012

Figure 9: Clinical Supply Chain Management, Distribution Models, 2012

Figure 10: Clinical Supply Chain Management, Segments of Distribution Model, 2012 Figure 11: Clinical Supply Chain Management, Inventory Management Stages, 2012

Figure 12: Clinical Supply Chain Management, Factors Resulting in Efficient Supply Chain, 2012 Figure 13: Clinical Supply Chain Management, R&D Expenditure Versus Turnover for the Top Ten Pharmaceutical Companies, 2011

Figure 14: Clinical Supply Chain Management, Key Factors Responsible for Study Timeline Reduction by SMOs, 2011

Figure 15: Clinical Supply Chain Management, Site Initiation Process, 2011

Figure 16: Clinical Supply Chain Management, Technologies Used for Forecasting, 2012

Figure 17: Clinical Supply Chain Management, Clinical Data Management System Flow, Global, 2012 Figure 18: Clinical Supply Chain Management, Use of IVRS in the Shipment Request Process for Inventory Management, 2011

Figure 19: Clinical Supply Chain Management, Cost Saved by Using IVRS - Reduction in Averages, 2011 Figure 20: Clinical Supply Chain Management, Cost of Over-Recruitment by 10% in Different Study Samples, 2011

Figure 21: Clinical Supply Chain Management, A Typical Clinical Trial Management System, 2011 Figure 22: Clinical Supply Chain Management, EU Legislations, 2011

Ordering: Order Online - http://www.researchandmarkets.com/reports/2226324/

Order by Fax - using the form below

Order by Post - print the order form below and send to Research and Markets,

Guinness Centre, Taylors Lane, Dublin 8, Ireland.

(5)

Page 1 of 2

Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit

http://www.researchandmarkets.com/contact/

Order Information

Please verify that the product information is correct and select the format(s) you require.

Product Formats

Please select the product formats and quantity you require:

Contact Information

Please enter all the information below in BLOCK CAPITALS

Product Name: Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management

Web Address: http://www.researchandmarkets.com/reports/2226324/

Office Code: SC

Quantity

Electronic (PDF)

-Single User: USD 3500 Electronic (PDF)

-Site License: USD 7000 Electronic (PDF)

-Enterprisewide: USD 10500

Title: Mr Mrs Dr Miss Ms Prof

First Name: Last Name:

Email Address: * Job Title: Organisation: Address: City:

Postal / Zip Code: Country:

Phone Number: Fax Number:

(6)

Page 2 of 2

Payment Information

Please indicate the payment method you would like to use by selecting the appropriate box.

Please fax this form to:

(646) 607-1907 or (646) 964-6609 - From USA

+353-1-481-1716 or +353-1-653-1571 - From Rest of World

Pay by credit card: You will receive an email with a link to a secure webpage to enter yourcredit card details.

Pay by check: Please post the check, accompanied by this form, to: Research and Markets,

Guinness Center, Taylors Lane, Dublin 8, Ireland.

Pay by wire transfer: Please transfer funds to:

Account number 833 130 83

Sort code 98-53-30

Swift code ULSBIE2D

IBAN number IE78ULSB98533083313083 Bank Address Ulster Bank,

27-35 Main Street, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

References

Related documents

RESOLVED, that the Board of Directors of the Presbyterian Church (U.S.A.), A Corporation (“Corporation”) hereby approves the Grant Policy, attached as

The arrangement of the players in the field makes several combinations possible, the most common being the side combination plays between the full back, the inside midfielder and

While this progression was ushered in by the larger events within New Zealand as Maori have gained a political, social and cultural standing, Onuku Runanga, with help from ACT and

Rosenberg SA, Lotze MT, Muul LM, et al: A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2

Philip Lane went downstairs and pushed at the baize door; he looked into the pantry, but Baines was not there, then he set foot for the first time on the stairs to the

We will indicate how a combination of the UAS measure with a measure on the order of attachment to the head (OUAS) can capture spans and headedness in headed RST trees; we can

However, in Nassar, the Court’s decision to avoid the burden-shifting framework for one type of claim under Title VII, while it remains applicable to status-based claims under

Explosion is student loan payments on housing crisis for calculating his way to know about fha loans before the child support to the debt.. Concluded that student loan obligations,